JPD:GBA帕金森病患者,体位性低血压明显

2022-05-19 Freeman MedSci原创

GBA-PD患者从仰卧位转变为直立位时收缩压下降得更明显

葡萄糖苷酶(GBA)基因的变异是帕金森病(PD)发病最常见的遗传风险因素。在一项包括1,360名参与者的大型国际综合基因筛查研究中,8.5%的帕金森病患者被发现携带杂合的GBA变体,其中最常见的是c.1093G>A(p.Glu365Lys,也称为E326K)和c.1223C>T(p.Thr408Met,也称为T369M)。在最近的一项荟萃分析中发现,这两个变异体在非阿什肯纳齐犹太人群中显著增加PD的风险。

图1:论文封面图

直立性低血压(OH)被定义为在站立3分钟内收缩压持续下降至少20毫米汞柱或舒张压下降10毫米汞柱。在PD中,OH的发生率为30-40%,取决于病程和疾病的严重程度。与GBA相关的PD(GBA-PD)患者报告自律神经症状,如OH,比特发性PD(IPD)患者更频繁,程度更严重。

与这些报告相反,一项针对1435名PD患者的大型国际研究和最近的荟萃分析没有发现GBA-PD和IPD患者之间有不同的OH频率;然而,仍然不能确定如何评估OH。

OH与认知能力下降以及姿势不稳和步态困难表型(PIGD)有关。这些临床特征在GBA-PD中也比IPD中更常见。PD中的OH主要是由于心血管症状神经支配导致的肾上腺素缺乏的结果。

以前的一份报告发现,与IPD相比,GBA-PD的心肌(123)I-metaiodo-benzylguanidine摄取量有更大的减少,这表明GBA-PD的交感神经失调更为明显。

为了解决GBA-PD与IPD相比在OH发生率方面的矛盾,德国University of Lubeck的Tatiana Usnich等人,在以前描述的和同时扩大的PD队列中进行了OH分析。他们旨在评估GBA-PD与IPD相比,从仰卧位转为直立位时的血压变化,并捕捉在改变体位时发生的任何相关症状。

与特发性帕金森病患者(IPD)相比,携带葡萄糖脑苷脂酶(GBA)基因变体的帕金森病患者(GBA-PD)更频繁地出现正压症状。

他们对33名GBA-PD和313名IPD患者进行了前瞻性分析。

与IPD患者相比,GBA-PD患者从仰卧位转变为直立位时收缩压下降得更明显

图2:论文结果图

舒张压和心率在组间没有差异。

这项研究为GBA-PD中自律神经系统的明显参与提供了进一步证据。


原文出处:
on behalf of the EPIPARK Study Group, Usnich T, Hanssen H, et al. Pronounced Orthostatic Hypotension in GBA-Related Parkinson’s Disease. JPD. Published online April 28, 2022:1-6. doi:10.3233/JPD-223197

 

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
    2022-08-20 laiminchao

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1239913, encodeId=e0001239913a1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9c3032606, createdName=laiminchao, createdTime=Sat Aug 20 08:07:25 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757452, encodeId=f7421e57452f8, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sat Apr 15 08:51:20 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367433, encodeId=357e136e433cf, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573965, encodeId=7b7415e39654f, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 20 05:51:20 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220934, encodeId=c1c312209344b, content=111, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43958165571, createdName=ms9000000795072041, createdTime=Thu May 19 14:51:39 CST 2022, time=2022-05-19, status=1, ipAttribution=)]
    2022-05-19 ms9000000795072041

    111

    3

    展开3条回复

相关资讯

JPD:低频率的前庭噪音刺激,或可改善帕金森患者姿势障碍

在接受低强度nGVS治疗的患者中,至少有一半的患者在姿势平衡方面表现出与SR相符的有力改善

JPD:人格测试,有助于帕金森病基本分类

早期帕金森病患者的性格使我们能够识别3种患者的表型

JPD:冷漠反映了新发帕金森病的纹状体外多巴胺能变性

孤立的帕金森病患者与纹状体外多巴胺能变性有关。

Neurology:神经丝光与帕金森病的发展和严重程度的关联

血液生物标记物可能有助于早期识别帕金森氏病(PD)、帕金森氏症及PD相关不良结局。近日,研究人员发现Nf-L与临床帕金森病、帕金森症状和身体功能下降有关。Nf-L或为神经退行性变潜在生物标记物。

JPD:帕金森患者的抑郁发病情况如何?

帕金森患者的患病率多少?

拓展阅读

好文推荐 | 八段锦对轻中度帕金森病患者情绪及睡眠质量的影响

本研究探讨八段锦对PD患者的情绪和睡眠质量的改善及其机制。

Nat Aging:大规模蛋白质组学分析揭示帕金森病的新病理机制和潜在生物标志物

这项研究通过大规模蛋白质组学分析,揭示了帕金森病的新病理机制,并发现了多个潜在的生物标志物。

帕金森病无症状期诊断新突破:基于tRFs的血液检测方法

当前难以满足帕金森病早期诊断的需求,该研究提出了一种基于血液检测的无症状诊断新方法,通过定量分析转移RNA片段(tRFs)中重复序列基序,实现了对帕金森病的早期、精准且低成本的检测。

Brain:帕金森病中神经黑色素耗竭与皮质节律活动之间的关联

注意力相关的 α 波段活动与去甲肾上腺素能系统的功能障碍有关,与运动障碍相关的 β 活动反映了多巴胺能功能障碍。

帕金森病:中西医健康需求的质性研究

研究呼吁政策制定者、医疗机构与科研团队协同合作,推动中西医结合从“经验医学”向“精准医学”转型,为全球PD管理提供中国方案。

【协和医学杂志】帕金森病患者脑深部电刺激术后神经精神功能障碍发生率及其影响因素分析:一项前瞻性队列研究

本研究拟通过前瞻性队列研究进一步明确DBS治疗患者PND发生率,并分析其影响因素,以期为更准确地识别PND并制订有效的管理策略提供更高级别的数据支持。

帕金森病经颅超声检查中国指南

中国医师协会超声医师分会 · 2025-02-20

2025 BAN共识指南:帕金森病的管理-第II部分:非运动症状

巴西神经病学学会(BAN,Brazilian Academy of Neurology) · 2025-01-31

中国经颅超声检查帕金森病规范与诊断指南

中国医师协会超声医师分会 · 2025-02-14